Analytical Data
-
Gene name
bca-1
- Application
-
Alternative Names
bca-1; T13C5.5Beta carbonic anhydrase 1; EC 4.2.1.1
-
Species
Caenorhabditis elegans
-
Source
E. coli
-
Tag
N- His & C- Myc
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q22460
-
Expression Region
1-270aa
-
Molecular Weight
35.7 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
BCA-1, or B-cell chemokine 1, is a crucial chemokine involved in the regulation of immune responses, particularly in B-cell development and migration. It plays a significant role in the recruitment of B-cells to lymphoid tissues and is essential for the formation of germinal centers, which are vital for the generation of high-affinity antibodies. The study of BCA-1 recombinant protein has gained importance in immunology as it offers insights into the mechanisms of B-cell trafficking and their role in various diseases, including autoimmune disorders and cancers. Understanding the structure and functionality of BCA-1 can facilitate the development of therapeutics aimed at modulating immune responses. Additionally, research into BCA-1 has potential implications for enhancing vaccine efficacy by improving B-cell responses. Thus, investigating BCA-1 recombinant protein not only contributes to fundamental immunological knowledge but also has significant clinical relevance in developing targeted therapies for immune-related conditions.
